The Federal Circuit's Recent Written Description Ruling in Allergan v. MSN Labs: Implications for Pharmaceutical Patent Drafting and LitigationThe Federal Circuit affirmed that a feature can be non-essential based on patent documents' examination.The written description must align with claims for sufficiency in patent requirements.